Page last updated: 2024-09-03

clofarabine and Burkitt Lymphoma

clofarabine has been researched along with Burkitt Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Green, S; Schultz, L1
Beesley, AH; Cummings, AJ; de Klerk, NH; Firth, MJ; Ford, J; Freitas, JR; Kees, UR; Palmer, ML; Perera, KU; Weller, RE1

Reviews

1 review(s) available for clofarabine and Burkitt Lymphoma

ArticleYear
Rational Alternatives to Fludarabine and Cyclophosphamide-Based Pre-CAR Lymphodepleting Regimens in the Pediatric and Young Adult B-ALL Setting.
    Current oncology reports, 2023, Volume: 25, Issue:8

    Topics: Bendamustine Hydrochloride; Burkitt Lymphoma; Child; Clofarabine; Cyclophosphamide; Humans; Immunotherapy, Adoptive; Receptors, Antigen, T-Cell; Receptors, Chimeric Antigen; Young Adult

2023

Other Studies

1 other study(ies) available for clofarabine and Burkitt Lymphoma

ArticleYear
In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
    British journal of haematology, 2007, Volume: 137, Issue:2

    Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Burkitt Lymphoma; Child; Clofarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flavonoids; Humans; Inhibitory Concentration 50; Leukemia-Lymphoma, Adult T-Cell; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

2007